Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Rank in Stocks #28067
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Share Price
$1.51
Last synced: 2026-07-31
Market Cap
$28.82M
Change (1 day)
-0.33%
Change (1 year)
-57.49%
Country
IT
Trade Genenta Science S.p.A. (GNTA)

Category

Stock split history for Genenta Science S.p.A. (GNTA)
Genenta Science S.p.A. stock (symbol: GNTA) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One GNTA share bought prior to Aug 20, 2026 would equal to 0 GNTA shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH